Skip to main content
OpenTrials

Clinical trial condition

Lymphangioleiomyomatosis

Explore clinical trials studying Lymphangioleiomyomatosis. Study availability and eligibility vary by location and protocol.

31 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Lymphangioleiomyomatosis trial results

Recruiting

TSC Biosample Repository and Natural History Database

NCT05676099

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Loma Linda University Children's Hospital Loma Linda, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center Oakland, California, United States
View all 26 locations
View Trial Details
Recruiting

Safety and Durability of Sirolimus for Treatment of LAM

NCT02432560

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 20 locations
View Trial Details
Completed

Letrozole for Lymphangioleiomyomatosis

NCT01353209

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View Trial Details

Related conditions